Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL)
| Assets | $12.73M |
| Expense Ratio | 1.01% |
| PE Ratio | 10.92 |
| Shares Out | 2.05M |
| Dividend (ttm) | $0.12 |
| Dividend Yield | 2.06% |
| Ex-Dividend Date | Jun 25, 2024 |
| Payout Ratio | 22.47% |
| 1-Year Return | -28.05% |
| Volume | 107,394 |
| Open | 6.23 |
| Previous Close | 6.27 |
| Day's Range | 5.94 - 6.23 |
| 52-Week Low | 4.57 |
| 52-Week High | 9.97 |
| Beta | 2.53 |
| Holdings | 49 |
| Inception Date | Nov 15, 2017 |
About PILL
Fund Home PageThe Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL) is an exchange-traded fund that is based on the S&P Pharmaceuticals Select Industry index. The fund provides 3x daily exposure to a modified equal-weighted index of pharmaceutical companies in the US. PILL was launched on Nov 15, 2017 and is issued by Direxion.
Top 10 Holdings
259.02% of assets| Name | Symbol | Weight |
|---|---|---|
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 122.02% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 49.48% |
| S&P PHARMACEUTICALS SELECT INDEX SWAP | n/a | 47.76% |
| DREYFUS GOVT CASH MAN INS | n/a | 18.03% |
| GOLDMAN SACHS FIN GOV 465 INSTITUT | n/a | 5.31% |
| Axsome Therapeutics, Inc. | AXSM | 3.46% |
| Viatris Inc. | VTRS | 3.28% |
| Eli Lilly and Company | LLY | 3.27% |
| Pfizer Inc. | PFE | 3.22% |
| Catalent, Inc. | CTLT | 3.18% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 25, 2024 | $0.02194 | Jul 2, 2024 |
| Mar 19, 2024 | $0.02716 | Mar 26, 2024 |
| Dec 21, 2023 | $0.03825 | Dec 29, 2023 |
| Sep 19, 2023 | $0.03531 | Sep 26, 2023 |
| Jun 21, 2023 | $0.04923 | Jun 28, 2023 |
| Mar 21, 2023 | $0.01911 | Mar 28, 2023 |
News
3 Pharmaceutical ETFs That Could Be Due For A Rebound
These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.
3 Leveraged Healthcare ETFs Soaring This Month
The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidem...
With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF
With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performance...